Veriheal

FEBRUARY 21, 2023

Despite notable advances in MMJ research over the last decade, scientists have found that some states’ restrictions on qualifying conditions prevent millions of patients from getting the treatments they need—robbing them of potential relief offered by cannabinoid therapies. Many patients take MMJ for more reasons than one.

Access 98

Access Patients Chronic Pain Conditions 98

SpeedWeed

JULY 27, 2021

Keeping up with changing cannabis industry news is easy when you read and listen to the right cannabis websites, blogs, newsletters, and podcasts , but what about learning the laws and regulations that are unique to each state? Fortunately, there are a number of websites that keep updated information about state cannabis laws and rules.

Law 52

Law Policy Data Programs 52

Cannabis Law Report

JULY 27, 2021

His first initiative is co-authoring an original study on epilepsy using survey data gathered from RoC’s innovative Observational Research Registry (ORR). Schlienz and colleagues have published a paper summarizing ORR data from individuals with epilepsy in the medical journal Epilepsy & Behavior.

Data 105

Data Epilepsy Research and Development Clinical Trials 105

Cannabis Law Report

JULY 7, 2021

New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs. Data also demonstrated that none of the biological drugs selected for the comparison study proved to be anti-proliferative to any of the primary cell types assessed. For more information, visit www.mymd.com.

Pharmaceutical 105

Pharmaceutical Data Clinical Trials Research and Development 105

The Cannigma

NOVEMBER 23, 2021

The app helps patients make sense of their journey by simplifying the information and supplying data-driven insights into their regimen and its effects. We delve into how data can further our understanding of different types of cannabis and why standardization is desperately needed in the industry. Okay, we got to prove it.

Data 52

Data Patients Access Wellness and Beauty 52

MMJ Recs

MAY 3, 2024

The Arkansas medical marijuana program, established through the Arkansas Medical Marijuana Amendment in 2016, has paved the way for patients suffering from a variety of debilitating conditions to find relief and improved quality of life. Typically, medical marijuana cards need to be renewed annually.

Marijuana 52

Marijuana Treatment Compliance Compliance 52

Cannabis Law Report

JUNE 1, 2021

Given the size and scale of the study, RYAH has developed a custom software solution, using OAuth API-integration to protect the privacy of the participants in the study, with the goal of enabling a fully integrated, patient feedback and data collection capability. About RYAH Group, Inc. RYAH Group, Inc.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Canna Law Blog

NOVEMBER 21, 2022

According to the state’s own internal comment data, more than 98% of people who commented supported medical cannabis. ” It starts off with the obvious yet powerful statement that “Kentuckians throughout the Commonwealth suffer from a multitude of medical conditions from which they deserve relief.”

Decriminalization 90

Decriminalization Chronic Pain Conditions Data 90

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Therefore, the growing marijuana market lacks the clinical data needed to help marijuana businesses create new and better products.

Data 45

Data Research and Development Marijuana Collective 45

Cannabis Law Report

JUNE 23, 2021

RYAH is pleased to contribute RYAH’s IoT devices and data platform and work with Medicann toward perfecting prescribing practices and dosing regimens,” said Gregory Wagner , CEO of RYAH Group, Inc. With a strong IP portfolio, RYAH gathers deep and insightful data on the complete patient session and formulation life cycle.

Programs 100

Programs Data Events Collective 100

Cannabis Law Report

NOVEMBER 14, 2019

million adults are now using “street cannabis ” to treat the symptoms of chronic conditions , according to the largest poll of its kind. More than half (56 per cent) of those using cannabis for their conditions did so on a daily basis, with a further 23 per cent on a weekly basis. They write.

Conditions 45

Conditions Data Medicine Collective 45

Cannabis Law Report

JUNE 16, 2021

Genetic Screening Platform Technology and Data to Strengthen Entheon’s Psychedelic-Assisted Protocols. Lobo brings a highly experienced and specialized team of technology experts in the fields of genetics, diagnostics, data and analytics, as well as a fully operational 5,000 sq. Vancouver, British Columbia–(Newsfile Corp.

Research and Development 105

Research and Development Data Conditions Events 105

Cannabis Law Report

AUGUST 23, 2021

The TGA recently released a new medical cannabis dashboard detailing a variety of information on both SAS-A and SAS-B approvals. They announced that they’re ‘committed to ongoing transparency and will release additional datasets in the future’, such as data on Authorised Prescriber applications and the concentrations of active ingredients.

Chronic Pain 105

Chronic Pain Concentrates Conditions Data 105

Veriheal

DECEMBER 14, 2023

Study Results The study, published in CNS Drugs, tested 40 participants on their ability to complete neurological-based tests on pattern recognition, multitasking, reaction time, information processing, and working memory. If you’d like to learn more, our medical practitioners are available to help.

Chronic Pain 120

Chronic Pain Consumption Cannabis Marijuana 120

Cannabis Law Report

JANUARY 4, 2022

Assay”) as a Laboratory Developed Test (LDT), pending a final review of the assay’s validation data by NYSDOH. With the conditional approval, ADCL can immediately employ the Linea 2.0 With the conditional approval, ADCL can immediately employ the Linea 2.0 Visit adnas.com for more information. Assay (the “Linea 2.0

Conditions 52

Conditions Research and Development Therapy Supply Chain 52

Cannabis Law Report

JULY 19, 2021

The data from the study is expected to be embedded into the RYAH MD platform, with the goal of enabling healthcare professionals to administer THC, CBD and terpenes in milliliters, which are then expected to automatically be converted into milligrams to allow for a customized, targeted patient inhalation session. “Our billion by 2027.

Therapy 76

Therapy Data Research and Development Events 76

Veriheal

JUNE 27, 2023

After over four years of observation, the researchers found no traces of Chronic Obstructive Pulmonary Disease (COPD) —a condition commonly associated with tobacco smoking, characterized by coughing and shortness of breath—whether in developmental or advanced stages.

Research and Development 104

Research and Development Data Collective Vaping 104

Cannabis Law Report

SEPTEMBER 29, 2021

(NASDAQ and CSE: WTER) (the “Company”), the country’s largest independent alkaline company and The Clean Beverage Company™, today shared highlights from the most recent Nielsen data for the 52-week and 4-week periods ending September 11, 2021. The Company’s unit growth in Grocery outpaces the entire category by 12.6x in unit volume.

Data 52

Data Retail Supply Chain Food 52

Cannabis Law Report

JULY 11, 2022

Gavin Newsom signed budget trailer bill Assembly Bill 195 (AB-195) into law. AB-195 contains several significant reforms to California’s cannabis laws. Delivery Data Required to be Reported in Metrc. Another noteworthy change is that retail delivery data will be required to be entered into Metrc by January 1, 2023.

Cultivation 52

Cultivation Law Collective Retail 52

Cannabis Law Report

SEPTEMBER 22, 2021

Data indicates potential of drug candidate to deliver an extremely potent therapeutic benefit at a very low non-toxic dose. New data will be presented at the 4th Annual International Cannabinoid-Derived Pharmaceuticals Summit in Boston. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Watch how Supera-CBD works. “We

Pharmaceutical 52

Pharmaceutical Data CBD Clinical Trials 52

Veriheal

MARCH 29, 2023

The Relationship Between Marijuana Use and Psychosis Using the Optum Clinformatics DataMart Database , which functions as an anonymous Medicare Advantage and commercial claims database, scientists were able to gather data with unprecedented precision. How Several Sources of Data Were Used in the Research In 2019, an estimated 48.2

Legalization 57

Legalization Data Policy Cannabis 57

Cannabis Law Report

DECEMBER 8, 2021

Access to headline, upfront, milestone and royalty data. Under what conditions can the deal be terminated? Which jurisdiction does the company insist upon for agreement law? Access Psychiatry deal headline, upfront, milestone and royalty data. For more information about this report visit [link]. Astellas Pharma.

Access 52

Access Data Pharmaceutical Research and Development 52

Cannabis Law Report

DECEMBER 14, 2021

(“IGC” or the “Company”) today announced positive primary endpoint data for its Phase 1 clinical trial for IGC-AD1, which is a proprietary cannabinoid-based investigational new drug candidate for patients who have Alzheimer’s disease. Food and Drug Administration (FDA) on December 1, 2021. Claudia Grimaldi. info@igcinc.us

Clinical Trials 52

Clinical Trials Safety Data Patients 52

Cannabis Law Report

DECEMBER 3, 2021

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

Cannabis Law Report

NOVEMBER 9, 2021

BRAMPTON, Ontario–(BUSINESS WIRE)–DATA Communications Management Corp. The following table sets out selected historical consolidated financial information for the periods noted. About DATA Communications Management Corp. Additional information relating to DATA Communications Management Corp. TABLE 1.

Data 52

Data Business Supply Chain Banking 52

Cannabis Law Report

JULY 19, 2021

1 All sales figured sourced from BDSA Sales Data and the Company’s internal calculations. 2 All sales figures sourced from the May 2021 BDSA Sales Data. For further information regarding Halo, see Halo’s disclosure documents on SEDAR at www.sedar.com. For more information about Papa’s Herb, visit [link].

Collective 105

Collective Data Cultivation Events 105

Cannabis Law Report

MAY 10, 2022

More than half of all prescriptions for medicinal cannabis in Australia are written by doctors in Queensland, with prescriptions often given for conditions there is little evidence medicinal cannabis can treat, new research reveals. The researchers’ analysis found anxiety was the reason given for 16% of medicinal cannabis prescriptions.

Medicine 52

Medicine Clinical Trials Data Sleep 52

Cannabis Law Report

DECEMBER 2, 2021

The results of the clinical trial have been submitted in the Clinical/Statistical Report (“CSR”) filed with the FDA, and relevant data is also available on Form 8-K filed with the SEC on December 2, 2021. Alzheimer’s disease impacts about 50 million people worldwide and about 5.5 million individuals in the U.S. Claudia Grimaldi. info@igcinc.us

Clinical Trials 52

Clinical Trials Data Patients THC 52

Cannabis Law Report

AUGUST 2, 2021

The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.

CBD 105

CBD Data Sleep Clinical Trials 105

Cannabis Law Report

JULY 30, 2021

The Company believes this non-IFRS measure does not only provide management with comparable financial data for internal financial analysis but also provides meaningful supplemental information to investors. This press release contains “forward-looking information” within the meaning of applicable securities laws.

Events 105

Events Business Media Conditions 105

Cannabis Law Report

JULY 29, 2021

Ben Kaplan, CEO of Ehave, said, “We strongly believe there is a genetic predisposition to this condition and will be conducting a large-scale genetic analysis to isolate an individuals’ risk profile. If these visual disturbances occur frequently, you may have a condition called hallucinogen persisting perception disorder (HPPD).

Research and Development 105

Research and Development Conditions Data Patients 105

Cannabis Law Report

JUNE 28, 2021

See “Non-IFRS Financial Measures” below for more information regarding Ionic Brands ‘s use of Non-IFRS financial measures and other reconciliations. ** Q1 2021 including results from Cowlitz County Cannabis asset acquisition, effective March 8, 2021. These preliminary fiscal results represent forward-looking information.

Business 95

Business Supply Chain Data Concentrates 95

Cannabis Law Report

OCTOBER 26, 2021

Last week, the National Agricultural Statistics Service (NASS) began collecting data for its first ever Hemp Acreage and Production Survey. Yet, there is no comprehensive, national production data for it. All information reported by individuals will be kept confidential, as required by federal law.

Hemp 52

Hemp Agriculture Data Collective 52

Cannabis Law Report

JULY 9, 2021

The Horizons ETFs product family includes a broadly diversified range of solutions for investors of all experience levels to meet their investment objectives in a variety of market conditions. The prospectus contains important detailed information about the ETF. where applicable laws permit such activities. federal law.

Data 105

Data Clinical Trials Decriminalization Hemp 105

The Cannigma

MARCH 14, 2023

Those who were already under close watch by law enforcement because of structural racism, as well as those who were responsible for the well being of others had to be very careful about how they were perceived by those in control of the laws. This included whether they had access to educational information about cannabis.

Policy 96

Policy Research and Development Conditions Consumption 96

Cannabis Law Report

SEPTEMBER 17, 2021

Spotlight PA sought that information while reporting on Tyler Cordeiro, a Bucks County man who was wrongly denied addiction treatment funding because of his medical marijuana card. At one point, attorneys for the Department of Health suggested that disclosing the information could lead to a criminal charge against an employee.

Treatment 52

Treatment Patients Data Policy 52

Canna Law Blog

JANUARY 23, 2023

I do think it’s an okay resource for very general information, but the legal fate of your cannabis business probably shouldn’t hinge on a more sophisticated, responsive form of google. They may also provide guidance on intellectual property and contract law issues related to cannabis.

Compliance 71

Compliance Compliance Cannabis Data 71